Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

PHASE3CompletedINTERVENTIONAL
Enrollment

858

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

Placebo

Once daily, matching placebo capsules, orally

DRUG

Idalopirdine

Once daily, encapsulated tablets, orally

Trial Locations (162)

Unknown

US338, Phoenix

US342, Fayetteville

US322, Anaheim

US305, Carson

US346, Costa Mesa

US327, Fullerton

US315, Lomita

US351, Oceanside

US307, Redlands

US301, Santa Rosa

US337, New London

US332, Stamford

US308, Delray Beach

US320, Hallandale

US347, Hialeah

US340, Lake Worth

US303, Miami

US313, Miami

US335, Naples

US345, Orange City

US309, Palm Beach Gardens

US302, Sunrise

US304, Atlanta

US360, Augusta

US318, Decatur

US334, Lake Charles

US350, Belmont

US344, Boston

US310, Saint Paul

US321, Hattiesburg

US330, Creve Coeur

US339, Paterson

US312, Staten Island

US316, Charlotte

US336, Winston-Salem

US323, Cincinnati

US349, Cleveland

US306, Columbus

US352, Lakewood

US333, Oklahoma City

US314, Allentown

US324, Pittsburgh

US341, Pittsburgh

US325, Reading

US319, Port Royal

US356, Cordova

US343, Fort Worth

US354, Houston

AR303, Banfield

AR312, Buenos Aires

AR301, Ciudad Autonoma Buenos Aires

AR304, Ciudad Autonoma Buenos Aires

AR308, Ciudad Autonoma Buenos Aires

AR311, Ciudad Autonoma Buenos Aires

AR313, Ciudad Autonoma Buenos Aires

AR314, Ciudad Autonoma Buenos Aires

AR315, Ciudad Autonoma Buenos Aires

AR307, Córdoba

AR309, Córdoba

AR305, Godoy Cruz

AR310, Mendoza

AR302, Santa Fe

AR306, Santiago del Estero

BR307, Curitiba

BR309, Curitiba

BR301, Rio de Janeiro

BR306, Rio de Janeiro

BR308, São Paulo

CA301, Halifax

CA302, Kelowna

CA306, Montreal

CA304, Qubec

CA303, Sherbrooke

CA305, Toronto

HR304, Zabok

HR301, Zagreb

HR302, Zagreb

HR303, Zagreb

CZ305, Brno

CZ306, Choceň

CZ309, Choceň

CZ308, Pardubice

CZ301, Prague

CZ303, Prague

CZ304, Prague

CZ307, Prague

CZ310, Praha 10 - Strasnice

CZ302, Rychnov nad Kněžnou

EE301, Tallinn

EE303, Tallinn

EE302, Tartu

FI302, Kuopio

FI303, Oulu

FI301, Turku

FR301, Bordeaux

FR308, Bron

FR307, Colmar

FR304, Dijon

FR309, Élancourt

FR302, Marseille

FR303, Nice

FR306, Reims

FR305, Rouen

HU304, Budapest

HU305, Budapest

HU301, Esztergom

HU303, Győr

HU302, Szeged

IE301, Cork

IL302, Haifa

IL303, Holon

IL304, Ramat Gan

IT306, Brescia

IT309, Brescia

IT311, Genova

IT312, Monza

IT302, Naples

IT313, Palermo

IT307, Perugia

IT301, Pisa

IT305, Roma

IT308, Roma

IT304, Torino

IT310, Torrette

LT302, Kaunas

LT303, Kaunas

LT301, Vilnius

LT304, Vilnius

PL301, Bialystok

PL304, Bydgoszcz

PL308, Gdynia

PL309, Krakow

PL302, Lodz

PL310, Lubin

PL306, Lublin

PL307, Oświęcim

PL303, Poznan

PT301, Amadora

PT302, Coimbra

KR303, Busan

KR301, Incheon

KR308, Seongnam-si

KR302, Seoul

KR304, Seoul

KR305, Seoul

KR306, Seoul

KR307, Seoul

KR309, Seoul

TW301, Kaohsiung City

TW302, Kaohsiung City

TW303, Taichung

TW304, Taipei

TW305, Taipei

GB307, Amersham

GB301, Glasgow

GB303, London

GB308, London

GB306, Plymouth

GB305, Preston

GB304, Southampton

GB302, Swindon

GB309, Warrington

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY